Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Grace Montgomery

Having built up two years knowledge of the global pharmaceutical industry, Grace reports on a wide range of topics including companies' business strategies, regulatory affairs, market research and product pipelines. Along with story sourcing, she particularly enjoys analyzing industry reports and highlighting companies' corporate business plans, and has attended industry conferences to network and attain exclusive content. Grace enjoys puzzles, baking and keeping active.
Advertisement
Set Alert for Articles By Grace Montgomery

Latest From Grace Montgomery

Zentiva Set To Acquire Romania's Solacium

Zentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company, entering into a shared purchase agreement with Siyiara to acquire Romania-based food supplement and OTC medicines producer Solacium.
Deals Romania

Eastern European Results Roundup: Grindeks, Alkaloid, Olainfarm, Podravka, Sopharma

Several Eastern European generics companies achieved sales growth in 2018. Looking ahead, Grindeks plans to strengthen its presence in Russia and other CIS countries, Alkaloid is set to continue investing in production facilities and technologies, while Olainfarm looks to upgrade its product dossiers.

Europe Companies

Zentiva Set To Acquire Romania's Solacium

Zentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company, entering into a shared purchase agreement with Siyiara to acquire Romania-based food supplement and OTC medicines producer Solacium.

Romania M & A

FDA Warns Teva's Actavis Over Quality Concerns

Quality issues and inconsistencies with laser-drilled tablet manufacturing processes at Teva’s Actavis have been flagged up by the FDA following an audit last July at the firm’s plant in Florida, US. The agency noted that similar cGMP observations were found during inspections in 2013, 2016 and 2017.

United States Manufacturing

People Roundup – 7 March 2019

Biocon believes its new biologics chief in India will lead the firm to become a “major global player”, Glenmark names Riva to lead its recently spun-off innovation business, and Recipharm bolsters its management team by adding Chouhan to lead sales activity in North America.

Appointments Companies

AAM Supports CMS' Revised Generic Drug Tiering Policies

The AAM says that it supports drug plans that automatically include generics and biosimilars on generic formulary tiers immediately after launch, in response to a CMS 2020 call letter. To support its position, the association is citing a report from Avalere that quantifies potential savings from revising Part D generics tiering.

Medicare Medicaid
See All
Advertisement
UsernamePublicRestriction

Register